Literature DB >> 2517627

Oxicams: metabolic disposition in man and animals.

T F Woolf1, L L Radulovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2517627     DOI： 10.3109/03602538909029942

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  6 in total

1.  Importance of substituents in ring opening: a DFT study on a model reaction of thiazole to thioamide.

Authors:  Xue Bai; Dan Qin; Lijun Yang
Journal:  J Mol Model       Date:  2021-02-21       Impact factor: 1.810

Review 2.  Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.

Authors:  K T Olkkola; A V Brunetto; M J Mattila
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

3.  Metabolic disposition of the non-steroidal anti-inflammatory agent isoxicam in man.

Authors:  T F Woolf; A Black; A Sedman; T Chang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

Review 4.  Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.

Authors:  C R Lee; J A Balfour
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of tenoxicam.

Authors:  O G Nilsen
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

Review 6.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.